HRS-1167
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for HRS-1167, covering 2024-04-11 to 2025-09-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone [Phase 1, Phase 2]